Duration of Anticoagulation
Showing 1 - 25 of >10,000
Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)
Active, not recruiting
- Venous Thrombosis
- +2 more
- 12-month Edoxaban
- 3-month Edoxaban
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Aug 16, 2022
Venous Thrombosis, Tumors, Anticoagulants Trial in Kyoto (Long DOAC, Short DOAC)
Recruiting
- Venous Thrombosis
- +2 more
- Long DOAC
- Short DOAC
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Mar 29, 2022
Deep Vein Thrombosis, Pulmonary Embolism Trial in Bologna (Vitamin K antagonist (Coumarin anticoagulants))
Completed
- Deep Vein Thrombosis
- Pulmonary Embolism
- Vitamin K antagonist (Coumarin anticoagulants)
-
Bologna, BO, ItalyDept. of Angiology & Blood Coagulation, University Hospital S. O
Mar 18, 2021
DULCIS
Completed
- Venous Thromboembolism
- D-dimer
-
Bologna, ItalyU.O. Angiologia e Malattie della Coagulazione "Marino Golinelli"
Mar 18, 2021
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs
Completed
- Venous Thromboembolism
- Anticoagulants and Bleeding Disorders
- Oral Anticoagulant
-
Oakland, California
- +1 more
Oct 31, 2022
Venous Thrombosis Trial in Worldwide (Shortened duration (6 weeks) of anticoagulant therapy, Conventional duration (3 months) of
Completed
- Venous Thrombosis
- Shortened duration (6 weeks) of anticoagulant therapy
- +2 more
-
Birmingham, Alabama
- +62 more
Mar 1, 2022
Atrial Fibrillation, Atrial Flutter, Adherence, Medication Trial in Worcester, Ann Arbor (Storytelling Intervention)
Not yet recruiting
- Atrial Fibrillation
- +6 more
- Storytelling Intervention
-
Worcester, Massachusetts
- +1 more
Aug 11, 2023
Anticoagulation, Atrial Fibrillation, Atrial Flutter Trial (Panel Management for Anticoagulation Therapy, Usual Care)
Withdrawn
- Anticoagulation
- +6 more
- Panel Management for Anticoagulation Therapy
- Usual Care
- (no location specified)
Aug 2, 2022
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Completed
- Ischemic Stroke
- +4 more
- not applicable (observational study)
-
Heidelberg, GermanyUniversity Hospital Heidelberg
Nov 1, 2022
Angina, Stable, Angina, Unstable, Anticoagulants Trial in Worldwide (COBRA PzF, Drug Eluting Stent)
Active, not recruiting
- Angina, Stable
- +2 more
- COBRA PzF
- Drug Eluting Stent
-
Newark, Delaware
- +47 more
Oct 23, 2020
Acute Kidney Injury Trial in São Paulo (Effects of increased blood flow during regional anticoagulation with 4% trisodium
Recruiting
- Acute Kidney Injury
- Effects of increased blood flow during regional anticoagulation with 4% trisodium citrate in patients undergoing continuous venovenous hemodiafiltration
-
São Paulo, BrazilHospital Israelite Albert Einstein
Apr 4, 2023
Venous Thromboembolism Trial in Beijing
Recruiting
- Venous Thromboembolism
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Oct 5, 2023
Chronic Kidney Diseases, Atrial Fibrillation, Stroke Trial (Apixaban 2.5 milligram Oral Tablet)
Not yet recruiting
- Chronic Kidney Diseases
- +8 more
- Apixaban 2.5 milligram Oral Tablet
- (no location specified)
Jan 8, 2023
Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism Trial in Nashville (Low intensity
Recruiting
- Acute Hypoxemic Respiratory Failure
- +2 more
- Low intensity anticoagulation
- Moderate Intensity Anticoagulation
-
Nashville, TennesseeVanderbilt University Medical Center
May 15, 2022
Post COVID-19 Patients Trial in Giza (hyperbaric oxygen therapy, breathing exercise, medical treatment)
Completed
- Post COVID-19 Patients
- hyperbaric oxygen therapy
- +2 more
-
Giza, EgyptFaculty of Physical Therapy
Aug 3, 2023
Hemorrhagic and Ischemic Events in Post-angioplasty in
Recruiting
- Atrial Fibrillation
- +3 more
- Blood panel
-
Nîmes, FranceCHU de Nîmes
Jan 2, 2023
Pulmonary Embolism Trial in Prague (Thrombolytic, Standard anticoagulation)
Not yet recruiting
- Pulmonary Embolism
- Thrombolytic
- Standard anticoagulation
-
Prague, CzechiaUniversity Hospital Kralovske Vinohrady
Aug 5, 2022
Quantitative 3-Dimensional Chest CT Vascular Reconstruction
Recruiting
- Pulmonary Embolism
- Contrast-enhanced chest CT
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 5, 2022
Left Atrial Appendage Occlusion Trial in Barcelona (Apixaban vs. DAPT)
Completed
- Left Atrial Appendage Occlusion
- Apixaban vs. DAPT
-
Barcelona, SpainHospital Clinic Barcelona
Nov 21, 2022
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- (no location specified)
Mar 31, 2023
Left Atrial Appendage Closure, Thrombosis, Stroke Trial in Quebec (Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel
Recruiting
- Left Atrial Appendage Closure
- +4 more
- Rivaroxaban, dabigatran, apixaban, or edoxaban
- +2 more
-
Quebec, CanadaJosep Rodes-Cabau
Jul 12, 2022
Endovascular Therapy in Patients With Acute Deep Vein Thrombosis
Completed
- Acute Deep Venous Thrombosis
- Mechanical / pharmacomechanical thrombectomy plus local catheter directed thrombolysis
- Local catheter directed thrombolysis alone
-
Banská Bystrica, Slovakia
- +2 more
Apr 23, 2023
Atrial Fibrillation Trial in Worldwide (WATCHMAN FLX Implant, Market-approved OAC)
Active, not recruiting
- Atrial Fibrillation
- WATCHMAN FLX Implant
- Market-approved OAC
-
Birmingham, Alabama
- +115 more
Jan 26, 2023